Detalles de la búsqueda
1.
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial.
Lancet
; 402(10411): 1423-1433, 2023 10 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37633306
2.
Baseline quality of life and chemotherapy toxicities in patients with early breast cancer.
Cancer
; 129(7): 1085-1095, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36642837
3.
Cutting Edge: mTORC1 Inhibition in Metastatic Breast Cancer Patients Negatively Affects Peripheral NK Cell Maturation and Number.
J Immunol
; 206(10): 2265-2270, 2021 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33931486
4.
Splenectomy in epithelial ovarian cancer surgery.
Int J Gynecol Cancer
; 33(6): 944-950, 2023 06 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36948526
5.
Association of chemotherapy and comorbidities with overall survival in elderly patients with early breast cancer: a French population-based propensity score-matched analysis.
Int J Clin Oncol
; 28(3): 371-381, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36645534
6.
Coffee and tea consumption, patient-reported, and clinical outcomes in a longitudinal study of patients with breast cancer.
Cancer
; 128(19): 3552-3563, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35913436
7.
Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations.
Br J Cancer
; 127(11): 1963-1973, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36207609
8.
Regorafenib or Tamoxifen for platinum-sensitive recurrent ovarian cancer with rising CA125 and no evidence of clinical or RECIST progression: A GINECO randomized phase II trial (REGOVAR).
Gynecol Oncol
; 164(1): 18-26, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34696892
9.
Impact of early palliative care on additional line of chemotherapy in metastatic breast cancer patients: results from the randomized study OSS.
Support Care Cancer
; 31(1): 82, 2022 Dec 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36574052
10.
Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant.
Breast Cancer Res
; 23(1): 57, 2021 05 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34020697
11.
Investigation of circulating metabolites associated with breast cancer risk by untargeted metabolomics: a case-control study nested within the French E3N cohort.
Br J Cancer
; 124(10): 1734-1743, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33723391
12.
Sarcopenia and serum biomarkers of oxidative stress after a 6-month physical activity intervention in women with metastatic breast cancer: results from the ABLE feasibility trial.
Breast Cancer Res Treat
; 188(3): 601-613, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34013451
13.
Poly(ADP-ribose) polymerase inhibitors in combination with anti-angiogenic agents for the treatment of advanced ovarian cancer.
Future Oncol
; 17(18): 2291-2304, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33726504
14.
Multicontrast MRI-based radiomics for the prediction of pathological complete response to neoadjuvant chemotherapy in patients with early triple negative breast cancer.
MAGMA
; 34(6): 833-844, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34255206
15.
Targeting AKT in ER-Positive HER2-Negative Metastatic Breast Cancer: From Molecular Promises to Real Life Pitfalls?
Int J Mol Sci
; 22(24)2021 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34948307
16.
Glucocorticoid Receptor: A Multifaceted Actor in Breast Cancer.
Int J Mol Sci
; 22(9)2021 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33923160
17.
ERα-36 regulates progesterone receptor activity in breast cancer.
Breast Cancer Res
; 22(1): 50, 2020 05 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32429997
18.
Prognostic value of CEC count in HER2-negative metastatic breast cancer patients treated with bevacizumab and chemotherapy: a prospective validation study (UCBG COMET).
Angiogenesis
; 23(2): 193-202, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31773439
19.
The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patients.
Cancer Immunol Immunother
; 69(5): 703-716, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32034426
20.
Design and methods of a national, multicenter, randomized and controlled trial to assess the efficacy of a physical activity program to improve health-related quality of life and reduce fatigue in women with metastatic breast cancer: ABLE02 trial.
BMC Cancer
; 20(1): 622, 2020 Jul 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32620149